Share Price and Basic Stock Data
Last Updated: January 22, 2026, 8:42 pm
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Hindustan Organic Chemicals Ltd operates in the organic chemicals sector, focusing on benzene-based products. The company’s stock price stood at ₹30.4, with a market capitalization of ₹204 Cr. Revenue trends indicate a fluctuating performance over the past few quarters, with sales recorded at ₹139 Cr in September 2022, rising to ₹194 Cr by March 2023, before declining to ₹145 Cr in June 2023. However, sales rebounded to ₹189 Cr in September 2023. For the trailing twelve months, total sales are reported at ₹592 Cr, reflecting an annual growth from ₹434 Cr in March 2022 to ₹631 Cr in March 2023, before a projected decline to ₹536 Cr in March 2025. This revenue trajectory highlights the volatility in demand and operational challenges faced by the company, which may be linked to broader market conditions in the chemicals sector.
Profitability and Efficiency Metrics
Hindustan Organic Chemicals Ltd’s profitability metrics reveal significant challenges. The operating profit margin (OPM) stood at -14%, indicating that expenses have consistently outpaced revenues. The company reported an operating profit of ₹6 Cr in March 2023, which declined to a loss of ₹1 Cr in March 2024 and further deteriorated to a projected loss of ₹86 Cr in March 2025. The interest coverage ratio (ICR) was reported at -1.48x, underscoring the difficulty in meeting interest obligations from operational earnings. The return on equity (ROE) was recorded at 21.6%, which contrasts sharply with the return on capital employed (ROCE) of just 5.20%. This disparity suggests that while equity holders may see some returns, the overall efficiency of capital utilization remains low, posing risks to long-term sustainability.
Balance Sheet Strength and Financial Ratios
The balance sheet of Hindustan Organic Chemicals Ltd shows a mixed picture of financial health. As of the latest reports, the company holds ₹953 Cr in reserves against borrowings of ₹232 Cr, indicating a relatively low debt level. The current ratio stood at 3.61x, suggesting a strong liquidity position, while the quick ratio was at 3.46x, confirming the ability to cover short-term liabilities. However, the company’s price-to-book value ratio (P/BV) is notably low at 0.27x, indicating that the market values the company significantly less than its book value. The total debt-to-equity ratio was reported at 0.19, reflecting a manageable level of debt compared to equity. Despite these strengths, the negative working capital days of 483 in March 2025 raise concerns about the operational efficiency and cash flow management.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Hindustan Organic Chemicals Ltd reflects a stable but cautious investor sentiment. Promoters hold 58.78% of the total shares, indicating strong management control and commitment. However, foreign institutional investors (FIIs) are absent, and domestic institutional investors (DIIs) hold a mere 0.02%, highlighting limited institutional interest. The public shareholding stands at 41.20%, with a total of 61,587 shareholders as of the latest report. This distribution suggests that while promoters maintain a strong position, the lack of institutional backing could limit growth opportunities and market confidence. The fluctuation in the number of shareholders, which increased from 47,994 in March 2023 to 61,922 in March 2025, indicates growing retail interest, yet the overall low DII participation signals a need for improved operational performance to attract larger institutional investments.
Outlook, Risks, and Final Insight
The outlook for Hindustan Organic Chemicals Ltd hinges on its ability to navigate operational challenges and improve profitability. Key strengths include a manageable debt level and a robust liquidity position, which provide a buffer against short-term financial pressures. However, risks are evident in the company’s consistent negative operating profit margins and low return on capital employed, which could deter potential investors. Additionally, the absence of institutional investors raises questions about long-term growth prospects. The company must focus on improving operational efficiency and cost management to enhance profitability. Success in these areas could positively influence investor sentiment and attract institutional interest, while failure to address these challenges could lead to continued volatility in performance and shareholder confidence.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Hindustan Organic Chemicals Ltd | 203 Cr. | 30.2 | 45.0/22.4 | 152 | 0.00 % | 5.20 % | 21.6 % | 10.0 | |
| Vinati Organics Ltd | 15,777 Cr. | 1,527 | 2,040/1,412 | 33.9 | 287 | 0.49 % | 20.6 % | 15.8 % | 1.00 |
| Seya Industries Ltd | 43.0 Cr. | 16.8 | 25.3/12.6 | 309 | 0.00 % | 0.51 % | 0.77 % | 10.0 | |
| Industry Average | 7,990.00 Cr | 524.67 | 33.90 | 249.33 | 0.16% | 8.77% | 12.72% | 7.00 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 139 | 174 | 194 | 145 | 189 | 187 | 183 | 59 | 175 | 165 | 137 | 164 | 126 |
| Expenses | 157 | 173 | 177 | 154 | 177 | 190 | 183 | 83 | 175 | 191 | 173 | 177 | 143 |
| Operating Profit | -17 | 1 | 16 | -9 | 11 | -3 | -1 | -24 | 0 | -26 | -37 | -13 | -17 |
| OPM % | -12% | 1% | 8% | -6% | 6% | -2% | -0% | -40% | 0% | -16% | -27% | -8% | -14% |
| Other Income | 9 | 3 | -5 | 3 | 5 | 4 | 7 | 5 | 5 | -35 | 551 | 13 | 5 |
| Interest | 13 | 17 | 17 | 17 | 17 | 18 | 17 | 16 | 18 | 18 | -10 | 5 | 5 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | -21 | -14 | -6 | -23 | -2 | -18 | -12 | -35 | -14 | -79 | 523 | -6 | -18 |
| Tax % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 1% | 0% | 0% |
| Net Profit | -21 | -14 | -6 | -23 | -2 | -18 | -12 | -35 | -14 | -79 | 520 | -6 | -18 |
| EPS in Rs | -3.12 | -2.01 | -0.63 | -3.44 | -0.21 | -2.65 | -1.77 | -5.27 | -2.03 | -11.76 | 77.39 | -0.94 | -2.70 |
Last Updated: January 6, 2026, 11:44 pm
Below is a detailed analysis of the quarterly data for Hindustan Organic Chemicals Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 126.00 Cr.. The value appears to be declining and may need further review. It has decreased from 164.00 Cr. (Jun 2025) to 126.00 Cr., marking a decrease of 38.00 Cr..
- For Expenses, as of Sep 2025, the value is 143.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 177.00 Cr. (Jun 2025) to 143.00 Cr., marking a decrease of 34.00 Cr..
- For Operating Profit, as of Sep 2025, the value is -17.00 Cr.. The value appears to be declining and may need further review. It has decreased from -13.00 Cr. (Jun 2025) to -17.00 Cr., marking a decrease of 4.00 Cr..
- For OPM %, as of Sep 2025, the value is -14.00%. The value appears to be declining and may need further review. It has decreased from -8.00% (Jun 2025) to -14.00%, marking a decrease of 6.00%.
- For Other Income, as of Sep 2025, the value is 5.00 Cr.. The value appears to be declining and may need further review. It has decreased from 13.00 Cr. (Jun 2025) to 5.00 Cr., marking a decrease of 8.00 Cr..
- For Interest, as of Sep 2025, the value is 5.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 5.00 Cr..
- For Depreciation, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00 Cr..
- For Profit before tax, as of Sep 2025, the value is -18.00 Cr.. The value appears to be declining and may need further review. It has decreased from -6.00 Cr. (Jun 2025) to -18.00 Cr., marking a decrease of 12.00 Cr..
- For Tax %, as of Sep 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00%.
- For Net Profit, as of Sep 2025, the value is -18.00 Cr.. The value appears to be declining and may need further review. It has decreased from -6.00 Cr. (Jun 2025) to -18.00 Cr., marking a decrease of 12.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is -2.70. The value appears to be declining and may need further review. It has decreased from -0.94 (Jun 2025) to -2.70, marking a decrease of 1.76.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 3:33 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 236 | 178 | 143 | 176 | 275 | 503 | 325 | 407 | 434 | 631 | 704 | 536 | 592 |
| Expenses | 382 | 306 | 265 | 335 | 442 | 475 | 384 | 381 | 433 | 625 | 705 | 622 | 685 |
| Operating Profit | -146 | -129 | -121 | -159 | -167 | 28 | -58 | 27 | 1 | 6 | -1 | -86 | -93 |
| OPM % | -62% | -72% | -85% | -90% | -61% | 6% | -18% | 7% | 0% | 1% | -0% | -16% | -16% |
| Other Income | 6 | -26 | 15 | 6 | 63 | 117 | 21 | 21 | 34 | 6 | 18 | 526 | 534 |
| Interest | 43 | 53 | 69 | 98 | 78 | 68 | 58 | 54 | 66 | 67 | 70 | 43 | 19 |
| Depreciation | 19 | 10 | 10 | 9 | 6 | 3 | 3 | 3 | 1 | 1 | 1 | 2 | 2 |
| Profit before tax | -202 | -217 | -185 | -259 | -187 | 73 | -98 | -8 | -32 | -55 | -54 | 395 | 420 |
| Tax % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 1% | |
| Net Profit | -202 | -217 | -185 | -259 | -187 | 73 | -98 | -8 | -32 | -55 | -54 | 392 | 416 |
| EPS in Rs | -28.41 | -32.07 | -26.82 | -38.37 | -27.79 | 10.79 | -14.33 | 0.38 | -4.41 | -7.95 | -8.13 | 58.32 | 61.99 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -7.43% | 14.75% | -40.00% | 27.80% | 139.04% | -234.25% | 91.84% | -300.00% | -71.88% | 1.82% | 825.93% |
| Change in YoY Net Profit Growth (%) | 0.00% | 22.17% | -54.75% | 67.80% | 111.24% | -373.28% | 326.08% | -391.84% | 228.12% | 73.69% | 824.11% |
Hindustan Organic Chemicals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
No data available for the compounded sales growth chart.
Balance Sheet
Last Updated: December 4, 2025, 3:03 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 67 | 67 | 67 | 67 | 67 | 67 | 67 | 67 | 67 | 67 | 67 | 67 | 67 |
| Reserves | -707 | -933 | -1,121 | 52 | -33 | 44 | -50 | -36 | -72 | -118 | -119 | 978 | 953 |
| Borrowings | 556 | 698 | 703 | 603 | 609 | 606 | 521 | 518 | 1,226 | 1,286 | 1,362 | 219 | 232 |
| Other Liabilities | 412 | 459 | 584 | 1,103 | 1,018 | 837 | 841 | 895 | 258 | 242 | 264 | 304 | 286 |
| Total Liabilities | 329 | 292 | 234 | 1,825 | 1,662 | 1,555 | 1,379 | 1,444 | 1,479 | 1,478 | 1,575 | 1,568 | 1,539 |
| Fixed Assets | 151 | 137 | 125 | 1,689 | 154 | 170 | 174 | 136 | 155 | 165 | 226 | 227 | 230 |
| CWIP | 38 | 11 | 4 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 1 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 140 | 143 | 104 | 131 | 1,508 | 1,384 | 1,204 | 1,309 | 1,324 | 1,313 | 1,349 | 1,336 | 1,308 |
| Total Assets | 329 | 292 | 234 | 1,825 | 1,662 | 1,555 | 1,379 | 1,444 | 1,479 | 1,478 | 1,575 | 1,568 | 1,539 |
Below is a detailed analysis of the balance sheet data for Hindustan Organic Chemicals Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 67.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 67.00 Cr..
- For Reserves, as of Sep 2025, the value is 953.00 Cr.. The value appears to be declining and may need further review. It has decreased from 978.00 Cr. (Mar 2025) to 953.00 Cr., marking a decrease of 25.00 Cr..
- For Borrowings, as of Sep 2025, the value is 232.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 219.00 Cr. (Mar 2025) to 232.00 Cr., marking an increase of 13.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 286.00 Cr.. The value appears to be improving (decreasing). It has decreased from 304.00 Cr. (Mar 2025) to 286.00 Cr., marking a decrease of 18.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 1,539.00 Cr.. The value appears to be improving (decreasing). It has decreased from 1,568.00 Cr. (Mar 2025) to 1,539.00 Cr., marking a decrease of 29.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 230.00 Cr.. The value appears strong and on an upward trend. It has increased from 227.00 Cr. (Mar 2025) to 230.00 Cr., marking an increase of 3.00 Cr..
- For CWIP, as of Sep 2025, the value is 1.00 Cr.. The value appears to be declining and may need further review. It has decreased from 4.00 Cr. (Mar 2025) to 1.00 Cr., marking a decrease of 3.00 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 1,308.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,336.00 Cr. (Mar 2025) to 1,308.00 Cr., marking a decrease of 28.00 Cr..
- For Total Assets, as of Sep 2025, the value is 1,539.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,568.00 Cr. (Mar 2025) to 1,539.00 Cr., marking a decrease of 29.00 Cr..
Notably, the Reserves (953.00 Cr.) exceed the Borrowings (232.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -702.00 | -827.00 | -824.00 | -762.00 | -776.00 | -578.00 | -579.00 | -491.00 | 0.00 | 5.00 | -2.00 | -305.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 18 | 51 | 22 | 19 | 11 | 17 | 14 | 3 | 7 | 11 | 10 | 15 |
| Inventory Days | 150 | 208 | 230 | 319 | 176 | 74 | 95 | 103 | 111 | 44 | 53 | 52 |
| Days Payable | 317 | 406 | 733 | 941 | 477 | 133 | 66 | 30 | 58 | 34 | 50 | 42 |
| Cash Conversion Cycle | -149 | -146 | -481 | -604 | -291 | -43 | 43 | 76 | 60 | 21 | 13 | 24 |
| Working Capital Days | -534 | -744 | -1,311 | -2,729 | 330 | 235 | 79 | -15 | -134 | -159 | -199 | 483 |
| ROCE % | -91% | -17% | 16% | -7% | 9% | 4% | 1% | 1% | -5% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 58.33 | -8.05 | -8.24 | -4.37 | -1.31 |
| Diluted EPS (Rs.) | 58.33 | -8.05 | -8.24 | -4.37 | -1.31 |
| Cash EPS (Rs.) | 58.51 | -7.83 | -8.05 | -4.19 | -0.87 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 155.40 | -13.00 | -12.77 | -5.38 | -0.10 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 155.40 | -13.00 | -12.77 | -5.38 | -0.10 |
| Revenue From Operations / Share (Rs.) | 79.66 | 104.64 | 93.87 | 64.47 | 61.70 |
| PBDIT / Share (Rs.) | -9.42 | 2.33 | 1.90 | 3.45 | 7.10 |
| PBIT / Share (Rs.) | -9.67 | 2.12 | 1.72 | 3.28 | 6.67 |
| PBT / Share (Rs.) | 58.70 | -8.22 | -8.23 | -4.37 | -1.30 |
| Net Profit / Share (Rs.) | 58.27 | -8.04 | -8.23 | -4.37 | -1.30 |
| NP After MI And SOA / Share (Rs.) | 58.24 | -8.12 | -7.89 | -3.97 | -1.61 |
| PBDIT Margin (%) | -11.82 | 2.22 | 2.02 | 5.35 | 11.50 |
| PBIT Margin (%) | -12.13 | 2.02 | 1.83 | 5.08 | 10.80 |
| PBT Margin (%) | 73.68 | -7.85 | -8.76 | -6.77 | -2.11 |
| Net Profit Margin (%) | 73.14 | -7.68 | -8.76 | -6.77 | -2.11 |
| NP After MI And SOA Margin (%) | 73.11 | -7.76 | -8.41 | -6.15 | -2.60 |
| Return on Networth / Equity (%) | 37.47 | 0.00 | 0.00 | 0.00 | -34.97 |
| Return on Capital Employeed (%) | -5.43 | 14.22 | 11.03 | 13.99 | 16.73 |
| Return On Assets (%) | 25.04 | -3.47 | -3.56 | -1.81 | -0.75 |
| Long Term Debt / Equity (X) | 0.00 | -0.04 | 0.00 | 0.00 | 2.49 |
| Total Debt / Equity (X) | 0.19 | -16.20 | -16.51 | -197.52 | 13.60 |
| Asset Turnover Ratio (%) | 0.34 | 0.45 | 0.42 | 0.29 | 0.29 |
| Current Ratio (X) | 3.61 | 0.91 | 0.95 | 0.99 | 1.11 |
| Quick Ratio (X) | 3.46 | 0.86 | 0.91 | 0.94 | 1.06 |
| Inventory Turnover Ratio (X) | 8.58 | 8.48 | 6.77 | 4.34 | 3.97 |
| Interest Coverage Ratio (X) | -1.48 | 0.22 | 0.19 | 0.45 | 0.89 |
| Interest Coverage Ratio (Post Tax) (X) | -1.59 | 0.20 | 0.17 | 0.42 | 0.83 |
| Enterprise Value (Cr.) | 201.55 | 807.36 | 730.02 | 377.91 | 507.33 |
| EV / Net Operating Revenue (X) | 0.37 | 1.15 | 1.16 | 0.87 | 1.22 |
| EV / EBITDA (X) | -3.18 | 51.44 | 57.21 | 16.27 | 10.63 |
| MarketCap / Net Operating Revenue (X) | 0.53 | 0.37 | 0.23 | 0.43 | 0.64 |
| Price / BV (X) | 0.27 | -5.13 | -3.05 | -102.76 | 8.62 |
| Price / Net Operating Revenue (X) | 0.53 | 0.37 | 0.23 | 0.43 | 0.64 |
| EarningsYield | 1.37 | -0.20 | -0.35 | -0.14 | -0.04 |
After reviewing the key financial ratios for Hindustan Organic Chemicals Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 58.33. This value is within the healthy range. It has increased from -8.05 (Mar 24) to 58.33, marking an increase of 66.38.
- For Diluted EPS (Rs.), as of Mar 25, the value is 58.33. This value is within the healthy range. It has increased from -8.05 (Mar 24) to 58.33, marking an increase of 66.38.
- For Cash EPS (Rs.), as of Mar 25, the value is 58.51. This value is within the healthy range. It has increased from -7.83 (Mar 24) to 58.51, marking an increase of 66.34.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 155.40. It has increased from -13.00 (Mar 24) to 155.40, marking an increase of 168.40.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 155.40. It has increased from -13.00 (Mar 24) to 155.40, marking an increase of 168.40.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 79.66. It has decreased from 104.64 (Mar 24) to 79.66, marking a decrease of 24.98.
- For PBDIT / Share (Rs.), as of Mar 25, the value is -9.42. This value is below the healthy minimum of 2. It has decreased from 2.33 (Mar 24) to -9.42, marking a decrease of 11.75.
- For PBIT / Share (Rs.), as of Mar 25, the value is -9.67. This value is below the healthy minimum of 0. It has decreased from 2.12 (Mar 24) to -9.67, marking a decrease of 11.79.
- For PBT / Share (Rs.), as of Mar 25, the value is 58.70. This value is within the healthy range. It has increased from -8.22 (Mar 24) to 58.70, marking an increase of 66.92.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 58.27. This value is within the healthy range. It has increased from -8.04 (Mar 24) to 58.27, marking an increase of 66.31.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 58.24. This value is within the healthy range. It has increased from -8.12 (Mar 24) to 58.24, marking an increase of 66.36.
- For PBDIT Margin (%), as of Mar 25, the value is -11.82. This value is below the healthy minimum of 10. It has decreased from 2.22 (Mar 24) to -11.82, marking a decrease of 14.04.
- For PBIT Margin (%), as of Mar 25, the value is -12.13. This value is below the healthy minimum of 10. It has decreased from 2.02 (Mar 24) to -12.13, marking a decrease of 14.15.
- For PBT Margin (%), as of Mar 25, the value is 73.68. This value is within the healthy range. It has increased from -7.85 (Mar 24) to 73.68, marking an increase of 81.53.
- For Net Profit Margin (%), as of Mar 25, the value is 73.14. This value exceeds the healthy maximum of 10. It has increased from -7.68 (Mar 24) to 73.14, marking an increase of 80.82.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 73.11. This value exceeds the healthy maximum of 20. It has increased from -7.76 (Mar 24) to 73.11, marking an increase of 80.87.
- For Return on Networth / Equity (%), as of Mar 25, the value is 37.47. This value is within the healthy range. It has increased from 0.00 (Mar 24) to 37.47, marking an increase of 37.47.
- For Return on Capital Employeed (%), as of Mar 25, the value is -5.43. This value is below the healthy minimum of 10. It has decreased from 14.22 (Mar 24) to -5.43, marking a decrease of 19.65.
- For Return On Assets (%), as of Mar 25, the value is 25.04. This value is within the healthy range. It has increased from -3.47 (Mar 24) to 25.04, marking an increase of 28.51.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. It has increased from -0.04 (Mar 24) to 0.00, marking an increase of 0.04.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.19. This value is within the healthy range. It has increased from -16.20 (Mar 24) to 0.19, marking an increase of 16.39.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.34. It has decreased from 0.45 (Mar 24) to 0.34, marking a decrease of 0.11.
- For Current Ratio (X), as of Mar 25, the value is 3.61. This value exceeds the healthy maximum of 3. It has increased from 0.91 (Mar 24) to 3.61, marking an increase of 2.70.
- For Quick Ratio (X), as of Mar 25, the value is 3.46. This value exceeds the healthy maximum of 2. It has increased from 0.86 (Mar 24) to 3.46, marking an increase of 2.60.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 8.58. This value exceeds the healthy maximum of 8. It has increased from 8.48 (Mar 24) to 8.58, marking an increase of 0.10.
- For Interest Coverage Ratio (X), as of Mar 25, the value is -1.48. This value is below the healthy minimum of 3. It has decreased from 0.22 (Mar 24) to -1.48, marking a decrease of 1.70.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is -1.59. This value is below the healthy minimum of 3. It has decreased from 0.20 (Mar 24) to -1.59, marking a decrease of 1.79.
- For Enterprise Value (Cr.), as of Mar 25, the value is 201.55. It has decreased from 807.36 (Mar 24) to 201.55, marking a decrease of 605.81.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.37. This value is below the healthy minimum of 1. It has decreased from 1.15 (Mar 24) to 0.37, marking a decrease of 0.78.
- For EV / EBITDA (X), as of Mar 25, the value is -3.18. This value is below the healthy minimum of 5. It has decreased from 51.44 (Mar 24) to -3.18, marking a decrease of 54.62.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.53. This value is below the healthy minimum of 1. It has increased from 0.37 (Mar 24) to 0.53, marking an increase of 0.16.
- For Price / BV (X), as of Mar 25, the value is 0.27. This value is below the healthy minimum of 1. It has increased from -5.13 (Mar 24) to 0.27, marking an increase of 5.40.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.53. This value is below the healthy minimum of 1. It has increased from 0.37 (Mar 24) to 0.53, marking an increase of 0.16.
- For EarningsYield, as of Mar 25, the value is 1.37. This value is below the healthy minimum of 5. It has increased from -0.20 (Mar 24) to 1.37, marking an increase of 1.57.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Hindustan Organic Chemicals Ltd:
- Net Profit Margin: 73.14%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: -5.43% (Industry Average ROCE: 8.77%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 37.47% (Industry Average ROE: 12.72%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): -1.59
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 3.46
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 33.9)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.19
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 73.14%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Organic - Benzene Based | Ambalamugal PO, Ernakulam Kerala 682302 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Yogendra Prasad Shukla | Chairman & M.D & CFO |
| Mr. Subodh Kumar | Non Official Independent Director |
| Mr. Vinay Kumar Sharma | Non Official Independent Director |
| Mr. Manoj Sethi | Government Nominee Director |
| Ms. Vandana | Government Nominee Director |
FAQ
What is the intrinsic value of Hindustan Organic Chemicals Ltd?
Hindustan Organic Chemicals Ltd's intrinsic value (as of 22 January 2026) is ₹932.84 which is 2988.87% higher the current market price of ₹30.20, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹203 Cr. market cap, FY2025-2026 high/low of ₹45.0/22.4, reserves of ₹953 Cr, and liabilities of ₹1,539 Cr.
What is the Market Cap of Hindustan Organic Chemicals Ltd?
The Market Cap of Hindustan Organic Chemicals Ltd is 203 Cr..
What is the current Stock Price of Hindustan Organic Chemicals Ltd as on 22 January 2026?
The current stock price of Hindustan Organic Chemicals Ltd as on 22 January 2026 is ₹30.2.
What is the High / Low of Hindustan Organic Chemicals Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Hindustan Organic Chemicals Ltd stocks is ₹45.0/22.4.
What is the Stock P/E of Hindustan Organic Chemicals Ltd?
The Stock P/E of Hindustan Organic Chemicals Ltd is .
What is the Book Value of Hindustan Organic Chemicals Ltd?
The Book Value of Hindustan Organic Chemicals Ltd is 152.
What is the Dividend Yield of Hindustan Organic Chemicals Ltd?
The Dividend Yield of Hindustan Organic Chemicals Ltd is 0.00 %.
What is the ROCE of Hindustan Organic Chemicals Ltd?
The ROCE of Hindustan Organic Chemicals Ltd is 5.20 %.
What is the ROE of Hindustan Organic Chemicals Ltd?
The ROE of Hindustan Organic Chemicals Ltd is 21.6 %.
What is the Face Value of Hindustan Organic Chemicals Ltd?
The Face Value of Hindustan Organic Chemicals Ltd is 10.0.